Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> The precise improvement in scoring is undoubtedly present in the clinical trial paper, but isn't relevant to a FDA press release about their approval of the drug.

Exactly. If it isn’t harmful, it doesn’t have to be very helpful — the effect can be small and significant.



FWIW: the full prescribing information warns about risks of physical dependance and withdrawal symptoms. The drug also ends up in the mother's breast milk at low levels. (See full prescribing info PDF linked in the article.)


If it isn’t harmful

That’s a big “if” though.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: